[go: up one dir, main page]

GB9127041D0 - New use - Google Patents

New use

Info

Publication number
GB9127041D0
GB9127041D0 GB919127041A GB9127041A GB9127041D0 GB 9127041 D0 GB9127041 D0 GB 9127041D0 GB 919127041 A GB919127041 A GB 919127041A GB 9127041 A GB9127041 A GB 9127041A GB 9127041 D0 GB9127041 D0 GB 9127041D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB919127041A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Priority to GB919127041A priority Critical patent/GB9127041D0/en
Publication of GB9127041D0 publication Critical patent/GB9127041D0/en
Priority to ZA929738A priority patent/ZA929738B/en
Priority to KR1019940702038A priority patent/KR940703665A/en
Priority to CA002126211A priority patent/CA2126211A1/en
Priority to PCT/JP1992/001656 priority patent/WO1993012796A1/en
Priority to MX9207429A priority patent/MX9207429A/en
Priority to EP93900396A priority patent/EP0617622A1/en
Priority to AU31712/93A priority patent/AU661748B2/en
Priority to RU94031479/14A priority patent/RU94031479A/en
Priority to JP5511545A priority patent/JPH07506807A/en
Priority to HU9401833A priority patent/HUT68175A/en
Priority to HU95P/P00358P priority patent/HU211939A9/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/553—Renin inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB919127041A 1991-12-20 1991-12-20 New use Pending GB9127041D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GB919127041A GB9127041D0 (en) 1991-12-20 1991-12-20 New use
ZA929738A ZA929738B (en) 1991-12-20 1992-12-15 New use of amino acid derivatives.
HU9401833A HUT68175A (en) 1991-12-20 1992-12-18 Process for producing pharmaceutical compositions for treating glaucoma, containing renin inhibitors
PCT/JP1992/001656 WO1993012796A1 (en) 1991-12-20 1992-12-18 Use of renin inhibitors for the treatment of glaucoma
CA002126211A CA2126211A1 (en) 1991-12-20 1992-12-18 Use of renin inhibitors for the treatment of glaucoma
KR1019940702038A KR940703665A (en) 1991-12-20 1992-12-18 Use of renin inhibitors to treat glaucoma
MX9207429A MX9207429A (en) 1991-12-20 1992-12-18 NEW USE OF AMINO ACID DERIVATIVES.
EP93900396A EP0617622A1 (en) 1991-12-20 1992-12-18 Use of renin inhibitors for the treatment of glaucoma
AU31712/93A AU661748B2 (en) 1991-12-20 1992-12-18 Use of renin inhibitors for the treatment of glaucoma
RU94031479/14A RU94031479A (en) 1991-12-20 1992-12-18 New application of amino acid derivatives, treatment method, pharmaceutical composition
JP5511545A JPH07506807A (en) 1991-12-20 1992-12-18 Use of renin inhibitors for glaucoma treatment
HU95P/P00358P HU211939A9 (en) 1991-12-20 1995-06-22 Use of renin-inhibitors for treatment of glaucoma

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919127041A GB9127041D0 (en) 1991-12-20 1991-12-20 New use

Publications (1)

Publication Number Publication Date
GB9127041D0 true GB9127041D0 (en) 1992-02-19

Family

ID=10706572

Family Applications (1)

Application Number Title Priority Date Filing Date
GB919127041A Pending GB9127041D0 (en) 1991-12-20 1991-12-20 New use

Country Status (11)

Country Link
EP (1) EP0617622A1 (en)
JP (1) JPH07506807A (en)
KR (1) KR940703665A (en)
AU (1) AU661748B2 (en)
CA (1) CA2126211A1 (en)
GB (1) GB9127041D0 (en)
HU (2) HUT68175A (en)
MX (1) MX9207429A (en)
RU (1) RU94031479A (en)
WO (1) WO1993012796A1 (en)
ZA (1) ZA929738B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6581194A (en) * 1993-04-28 1994-11-21 Fujisawa Pharmaceutical Co., Ltd. Oral pharmaceutical compositions containing renin inhibitors
WO2001096310A1 (en) 2000-06-15 2001-12-20 Pharmacia Corporation Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
AR040126A1 (en) 2002-05-29 2005-03-16 Glaxo Group Ltd PHENYL SULFONYL COMPOUND, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND ITS USE FOR THE PREPARATION OF A MEDICINAL PRODUCT
EP2723718A1 (en) 2011-06-24 2014-04-30 Amgen Inc. Trpm8 antagonists and their use in treatments
WO2012177893A2 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
AU2021289665A1 (en) 2020-06-10 2022-12-15 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections
IL309732A (en) 2021-07-09 2024-02-01 Aligos Therapeutics Inc Anti-viral compounds
WO2023043816A1 (en) 2021-09-17 2023-03-23 Aligos Therapeutics, Inc. Anti-viral compounds for treating coronavirus, picornavirus, and norovirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906613A (en) * 1985-11-05 1990-03-06 Schering Corporation Antiglaucoma compositions and methods
US4921855A (en) * 1987-06-22 1990-05-01 Fujisawa Pharmaceutical Co., Ltd. New Histidyl amino acid derivatives, and pharmaceutical composition comprising the same
US4927807A (en) * 1987-10-06 1990-05-22 Abbott Laboratories Glaucoma treatment
US5151513A (en) * 1988-04-29 1992-09-29 E. R. Squibb & Sons, Inc. N-heterocyclic alcohol derivatives
IL99389A0 (en) * 1990-09-17 1992-08-18 Fujisawa Pharmaceutical Co Amino acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication number Publication date
CA2126211A1 (en) 1993-07-08
MX9207429A (en) 1993-06-01
AU661748B2 (en) 1995-08-03
HU211939A9 (en) 1996-01-29
RU94031479A (en) 1996-10-20
EP0617622A1 (en) 1994-10-05
HUT68175A (en) 1995-05-29
AU3171293A (en) 1993-07-28
WO1993012796A1 (en) 1993-07-08
KR940703665A (en) 1994-12-12
HU9401833D0 (en) 1994-09-28
JPH07506807A (en) 1995-07-27
ZA929738B (en) 1993-06-17

Similar Documents

Publication Publication Date Title
EP0746367A4 (en) Easy intubator
BG95816A (en) New sulphonylcarbamides
GB9127041D0 (en) New use
GB9217820D0 (en) New use
GB9101503D0 (en) New use
GB9121661D0 (en) New use
GB9104834D0 (en) New use
GB9104174D0 (en) New use
GB9108747D0 (en) New use
GB9109060D0 (en) New use
EP0524601A3 (en) Photocoupleur
GB9126476D0 (en) Use
GB9115143D0 (en) Novel use
GB9108326D0 (en) Novel use
HU913745D0 (en) New amino-ketones
AU206P (en) BUNDERRA Danthonia linkii
AU205P (en) TARANNA Danthonia richardsonii
AU213P (en) MOONBEAM Galtonia candicans
RU1806807C (en) Puzzle-game
AU352P (en) TRIUMPHANT Chamelaucium uncinatum
CA68506S (en) Pom-pom
CA68724S (en) Mobilier-jeu pedagogique
CA68731S (en) Moneybox
CA69416S (en) Orgnizer
AU204P (en) NIRIBI Chamelaucium uncinatum